Literature DB >> 9462286

Immunolocalization of CD18-positive cells in the bovine ovary.

K Spanel-Borowski1, P Rahner, A M Ricken.   

Abstract

The life cycle of follicles and of corpora lutea may be finely tuned by resident leucocytes in control of the angiogenesis, dilatation and permeability of microvessels, remodelling of the extracellular matrix, and phagocytosis of degenerated cells. Since the overall leucocyte distribution has not been studied in the bovine ovary, we located the CD18 molecule in this organ using indirect immunohistochemistry. This molecule represents a subtype of beta 2 integrin and is expressed by all subsets of leucocytes. The microvessels were also identified with an antibody against factor VIIIr antigen. The outer layer of the interstitial cortex, where the primordial follicles were located, contained a few CD18-positive cells and a few microvessels. Intact follicles displayed the CD18-positive cells in the theca. They were aligned in the zone of the basal membrane of preovulatory follicles. This was associated with a dilated inner microvessel layer. CD18-positive cells and probably capillary sprouts were seen in the granulosa layer of freshly ovulated follicles. Regressing follicles exhibited CD18-positive cells in the hypertrophied theca and in the degenerating granulosa layer, together with the pattern of capillary sprouts. At the developmental stage, corpora lutea exhibited many CD18-positive cells in the septa. The microvascular bed was expanding. At the secretory stage, a regular and moderate appearance of CD18-positive cells corresponded to a well-developed microvascular bed. Abundant positive cells were seen at the regressive stage, together with the development of shunt-like arterioles. The semiquantitative evaluation of leucocyte subsets in corpora lutea revealed an increased in the CD18-positive cells between stages of development and regression, which was not observed in the corresponding interstitial cortex. Lymphocytes with the expression of CD2, CD3 or both molecules displayed a similar behaviour. In conclusion, the CD18-positive leucocytes represent a heterologous pool with a distribution that varies in accordance with morphological changes in the follicles and corpora lutea.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9462286     DOI: 10.1530/jrf.0.1110197

Source DB:  PubMed          Journal:  J Reprod Fertil        ISSN: 0022-4251


  7 in total

Review 1.  Progress in focus: recent advances in histochemistry and cell biology.

Authors:  Esther Asan
Journal:  Histochem Cell Biol       Date:  2002-11-27       Impact factor: 4.304

2.  Follicular fluid expression of alpha-defensins and their role in ovulation.

Authors:  S Das; M D Bates; G S Vince; I Lewis-Jones; R Gazvani
Journal:  J Assist Reprod Genet       Date:  2008-01-29       Impact factor: 3.412

3.  Lipopolysaccharide initiates inflammation in bovine granulosa cells via the TLR4 pathway and perturbs oocyte meiotic progression in vitro.

Authors:  John J Bromfield; I Martin Sheldon
Journal:  Endocrinology       Date:  2011-10-11       Impact factor: 4.736

4.  Manipulating bovine granulosa cell energy metabolism limits inflammation.

Authors:  Anthony D Horlock; Thomas J R Ormsby; Martin J D Clift; José E P Santos; John J Bromfield; I Martin Sheldon
Journal:  Reproduction       Date:  2021-05       Impact factor: 3.923

Review 5.  The contribution of the maternal immune system to the establishment of pregnancy in cattle.

Authors:  Trudee Fair
Journal:  Front Immunol       Date:  2015-01-28       Impact factor: 7.561

Review 6.  Microvascular endothelial cells of the corpus luteum.

Authors:  John S Davis; Bo R Rueda; Katherina Spanel-Borowski
Journal:  Reprod Biol Endocrinol       Date:  2003-11-10       Impact factor: 5.211

7.  Transcriptomal profiling of bovine ovarian granulosa and theca interna cells in primary culture in comparison with their in vivo counterparts.

Authors:  Nicholas Hatzirodos; Claire Glister; Katja Hummitzsch; Helen F Irving-Rodgers; Philip G Knight; Raymond J Rodgers
Journal:  PLoS One       Date:  2017-03-10       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.